Waltham, MA, United States of America

Brian Booth

USPTO Granted Patents = 7 

Average Co-Inventor Count = 6.2

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Waltham, MA (US) (2023 - 2024)
  • West Roxbury, MA (US) (2024)

Company Filing History:


Years Active: 2023-2025

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations by Inventor Brian Booth

Introduction

Brian Booth is a notable inventor based in Waltham, Massachusetts, who has made significant contributions to the field of biotechnology. With a total of six patents to his name, Booth is recognized for his innovative work in developing humanized antibodies that target specific receptors in the human body.

Latest Patents

One of his latest patents is centered on "Humanized complement 5a receptor 1 antibodies and methods of use thereof." This innovation details the creation of two different formats of humanized antibodies against human complement component 5a receptor I. The patent also outlines a method for treating subjects suffering from dysfunctions of the C5a/C5aR1 axis pathway, such as ANCA-associated vasculitis. By administering an effective amount of the antibody or a nucleic acid encoding the antibodies that bind to C5aR1, the treatment aims to decrease symptoms associated with C5a/C5aR1 dysfunction in patients.

Career Highlights

Brian Booth plays a pivotal role at Visterra, Inc., where he continues to push the boundaries of therapeutic antibody development. His work is integral to advancing treatments that alleviate serious health conditions related to immune system dysfunctions.

Collaborations

Throughout his career, Booth has collaborated closely with professionals such as Karthik Viswanathan and Boopathy Ramakrishnan, amplifying the impact of his research through teamwork and shared expertise. These collaborations not only enhance the quality of his work but also contribute to the innovative environment at Visterra, Inc.

Conclusion

In summary, Brian Booth is a distinguished inventor whose work on humanized antibodies is paving the way for new treatments in the field of immunology. With a strong patent portfolio and valuable collaborations, he continues to be a key player in biotechnology innovation. His contributions will surely have a lasting impact on how we understand and treat immune system disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…